Background: This study assesses clinical outcomes after drug-eluting balloon treatment for
recurrent in-stent restenosis lesions based on the number of metallic layers. Methods and …

Treatment of patients with drug-eluting stent (DES) in-stent restenosis (ISR) is particularly
challenging. We sought to compare results of drug-eluting balloons in patients with DES-ISR …

Background Studies comparing the drug-eluting balloon (DEB) with contemporary drug-
eluting stent (DES) in the treatment of in-stent restenosis (ISR) have been scarce. We …

Objectives: This study aimed to investigate the clinical outcomes of patients presenting with
recurrent drug-eluting stent (DES) in-stent restenosis (ISR) treated with a second-generation …

Backgrounds In-stent restenosis (ISR) remains an important issue even in the current drug-
eluting stent (DES) era. We performed a meta-analysis to assess the clinical efficacy and …

Aims: Treatment of in-stent restenosis of coronary stents is challenging. The use of drug-
coated balloons (DCB) is a promising technique to treat in-stent restenosis without adding …

Objectives The aim of this study was to evaluate the long‐term clinical safety and efficacy of
drug‐coated balloon (DCB) in the treatment of in‐stent restenosis (ISR). Background There …

Background. Although drug‐eluting stents (DES) have reduced the rates of in‐stent
restenosis (ISR) compared with bare‐metal stents (BMS), DES related ISR (DES‐ISR) still …

Background In-stent restenosis (ISR) remains an important concern despite the recent
advances in the drug-eluting stent (DES) technology. The introduction of drug-eluting …

Background In-stent restenosis (ISR) remains a significant mode of stent failure following
PCI. The optimal treatment strategy, however, remains undefined and the role of drug …